EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PSMA4 as a Druggable Target in Hidradenitis Suppurativa: Evidence From Mendelian Randomization and Single‐Cell Transcriptomics

Siqing Guo iD, Li Gao, Yanting Sun, Lixin Yin iD, Peihong Li iD, Boyun Sun iD, Jingen Lu iD

Mediators of Inflammation · 2026

DOI: 10.1155/mi/4954996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2026. Verfasst von Siqing Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Proctology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, shutcm.edu.cn. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with limited treatment options and frequent drug resistance. Novel therapeutic targets are urgently needed. We performed a druggable genome‐wide Mendelian randomization (MR) analysis using blood cis‐expression quantitative trait locus (eQTL) and HS genome‐wide association study (GWAS) data. Colocalization, transcriptomic validation, single‐cell RNA sequencing, and cell–cell communication analyses were integrated to explore gene function and cell‐type specificity. We identified eight genes that showed significant associations with HS through MR analysis. Colocalization analysis further prioritized PSMA4 and MAST3 as the most promising druggable targets for HS. Specifically, PSMA4 (single nucleotide polymorphisms [SNPs] = 10; inverse‐variance weighted [IVW] OR = 1.912, 95% CI: 1.492–2.450, p < 0.001; PP.H4 = 0.975) and MAST3 (SNPs = 15; IVW OR = 0.557, 95% CI: 0.453–0.686, p < 0.001; PP.H4 = 0.832) exhibited strong statistical associations. Transcriptomic validation revealed that PSMA4 was upregulated and MAST3 was downregulated in HS lesions. Further single‐cell analysis revealed that PSMA4 was predominantly enriched in CD4 + T cells and involved in pro‐inflammatory signaling, particularly the tumor necrosis factor (TNF) pathway. PSMA4 and MAST3 are potential therapeutic targets for HS. PSMA4 may promote inflammation via CD4 + T cell‐mediated signaling, offering a novel avenue for treatment development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaHumansGenome-Wide Association StudyPolymorphism, Single NucleotideTranscriptomeMendelian Randomization AnalysisQuantitative Trait LociSingle-Cell Analysis

Stichwörter der Autor:innen

Mendelian randomizationhidradenitis suppurativainflammationtherapeutic targets

Autor:innen und Institutionen

  • Department of Proctology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, shutcm.edu.cn.
  • Shanghai Fengxian District Traditional Chinese Medicine Hospital, Shanghai, China.
  • Department of Gastroenterology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, shutcm.edu.cn.

ORCID-Profile: Siqing Guo, Lixin Yin, Peihong Li, Boyun Sun, Jingen Lu

Zitieren

APA

Guo, S., Gao, L., Sun, Y., Yin, L., Li, P., Sun, B., & Lu, J. (2026). PSMA4 as a Druggable Target in Hidradenitis Suppurativa: Evidence From Mendelian Randomization and Single‐Cell Transcriptomics. Mediators of Inflammation. https://doi.org/10.1155/mi/4954996

Vancouver

Guo S, Gao L, Sun Y, Yin L, Li P, Sun B, et al. PSMA4 as a Druggable Target in Hidradenitis Suppurativa: Evidence From Mendelian Randomization and Single‐Cell Transcriptomics. Mediators of Inflammation. 2026. doi:10.1155/mi/4954996

BibTeX
@article{Guo2026,
  author = {Guo, Siqing and Gao, Li and Sun, Yanting and Yin, Lixin and Li, Peihong and Sun, Boyun and Lu, Jingen},
  title = {PSMA4 as a Druggable Target in Hidradenitis Suppurativa: Evidence From Mendelian Randomization and Single‐Cell Transcriptomics},
  journal = {Mediators of Inflammation},
  year = {2026},
  doi = {10.1155/mi/4954996}
}
Kostenlos starten →